Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Remodulin approved in Canada

Oct. 8, 2002

Karo Bio presents thyroid receptor antagonists with potential in arrhythmia and other disorders

Oct. 8, 2002

Inhibitors of voltage-gated potassium channels in the ICAgen pipeline

Oct. 7, 2002

Pharmacokinetic data reported for extended-release lovastatin

Oct. 7, 2002

Antiarrhythmic series covered by AstraZeneca patent

Oct. 4, 2002

Cardioprotective effects of JTV-519 and relationship to nitric oxide synthase

Oct. 4, 2002

Enrollment completed in DIAMOND and SILVER ALT-711 trials

Oct. 2, 2002

New inhibitors of malonyl-CoA decarboxylase and their use in heart failure, diabetes, obesity, etc.

Oct. 2, 2002

Marketing approval granted for first aldosterone blocker in high blood pressure

Oct. 1, 2002

Final phase I results for Antrin phototherapy in coronary artery disease

Oct. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...